Swiss biotech industry
The Swiss biotech industry, headquartered in Switzerland (CH), is a dynamic sector renowned for its innovation and excellence in life sciences. Established in the early 1980s, this industry has seen significant milestones, including the emergence of leading companies that specialise in pharmaceuticals, diagnostics, and biomanufacturing. Core products and services range from cutting-edge therapeutics to advanced biotechnological solutions, setting Swiss firms apart with their commitment to quality and precision. The industry is recognised for its strong market position, with notable achievements in research and development, contributing to Switzerland's reputation as a global biotech hub. With a focus on sustainability and health advancements, the Swiss biotech sector continues to drive progress in the life sciences arena.
DitchCarbon Score
How does Swiss biotech industry's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Swiss biotech industry's score of 6 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Swiss biotech industry's reported carbon emissions
The Swiss biotech industry currently lacks specific emissions data, as no recent figures on carbon emissions have been provided. Consequently, there are no absolute emissions numbers to report, nor are there defined reduction targets or climate pledges from the industry. In the absence of concrete data, it is essential to note that the Swiss biotech sector is increasingly aware of its environmental impact and is likely to be exploring various initiatives to address climate change. The industry context suggests a growing commitment to sustainability, with many companies potentially aligning with global standards and frameworks aimed at reducing carbon footprints. As the industry evolves, stakeholders may implement strategies to measure and mitigate emissions across all scopes—Scope 1 (direct emissions), Scope 2 (indirect emissions from energy), and Scope 3 (indirect emissions from the value chain). Future commitments and initiatives are anticipated as the sector continues to prioritise climate action and sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Swiss biotech industry is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
